Evidence map›Paper›PMID 28378814›Full record

ArticleNature communications2017

Constitutive smooth muscle tumour necrosis factor regulates microvascular myogenic responsiveness and systemic blood pressure.

Jeffrey T Kroetsch, Andrew S Levy, Hangjun Zhang, Roozbeh Aschar-Sobbi, Darcy Lidington, Stefan Offermanns, Sergei A Nedospasov, Peter H Backx, Scott P Heximer, Steffen-Sebastian Bolz

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Molecular Mechanism Underlying Role of the XBP1s in Cardiovascular Diseases.Journal of cardiovascular development and disease · 2022
    Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Inflammation in Coronary Microvascular Dysfunction.International journal of molecular sciences · 2021
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Jeffrey T KroetschDepartment of Physiology, Faculty of Medicine, University of Toronto, 1 King's College Circle, Medical Sciences Building, Toronto, Ontario, Canada M5S 1A8.
Andrew S LevyDepartment of Physiology, Faculty of Medicine, University of Toronto, 1 King's College Circle, Medical Sciences Building, Toronto, Ontario, Canada M5S 1A8.
Hangjun ZhangDepartment of Physiology, Faculty of Medicine, University of Toronto, 1 King's College Circle, Medical Sciences Building, Toronto, Ontario, Canada M5S 1A8.
Roozbeh Aschar-SobbiDivision of Cardiology, University Health Network, R. Fraser Elliott Building, 1st Floor, 190 Elizabeth Street, Toronto, Ontario, Canada M5G 2C4.
Darcy LidingtonDepartment of Physiology, Faculty of Medicine, University of Toronto, 1 King's College Circle, Medical Sciences Building, Toronto, Ontario, Canada M5S 1A8.
Stefan OffermannsMax-Planck-Institute for Heart and Lung Research, Ludwigstrasse 43, 61231 Bad Nauheim, Germany.
Sergei A NedospasovEngelhardt Institute of Molecular Biology and Lemonosov Moscow State University, 32 Vavilov Street, Moscow 119991, Russia.
Peter H BackxDivision of Cardiology, University Health Network, R. Fraser Elliott Building, 1st Floor, 190 Elizabeth Street, Toronto, Ontario, Canada M5G 2C4.
Scott P HeximerDepartment of Physiology, Faculty of Medicine, University of Toronto, 1 King's College Circle, Medical Sciences Building, Toronto, Ontario, Canada M5S 1A8.
Steffen-Sebastian BolzDepartment of Physiology, Faculty of Medicine, University of Toronto, 1 King's College Circle, Medical Sciences Building, Toronto, Ontario, Canada M5S 1A8.
University of Toronto · CAUniversity Health Network · CALomonosov Moscow State University · RUMax Planck Institute for Heart and Lung Research · DESt. Michael's Hospital · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tumour necrosis factor (TNF) is a ubiquitously expressed cytokine with functions beyond the immune system. In several diseases, the induction of TNF expression in resistance artery smooth muscle cells enhances microvascular myogenic vasoconstriction and perturbs blood flow. This pathological role prompted our hypothesis that constitutively expressed TNF regulates myogenic signalling and systemic haemodynamics under non-pathological settings. Here we show that acutely deleting the TNF gene in smooth muscle cells or pharmacologically scavenging TNF with etanercept (ETN) reduces blood pressure and resistance artery myogenic responsiveness; the latter effect is conserved across five species, including humans. Changes in transmural pressure are transduced into intracellular signals by membrane-bound TNF (mTNF) that connect to a canonical myogenic signalling pathway. Our data positions mTNF 'reverse signalling' as an integral element of a microvascular mechanosensor; pathologic or therapeutic perturbations of TNF signalling, therefore, necessarily affect microvascular tone and systemic haemodynamics.

Indexed as

AnimalsBlood PressureDogsEtanerceptFemaleHeart FailureHumansMaleMesocricetusMice, Inbred C57BLMice, KnockoutMicrocirculationMuscle, SkeletalMuscle, Smooth, VascularSignal TransductionSpecies SpecificityEtanerceptTumor Necrosis Factor-alpha

Identifiers

PMID28378814
PMCPMC5382284
OpenAlexW2604753011

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.